Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9098 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9098 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.903 |
High Similarity |
NPD1549 |
Phase 2 |
0.8947 |
High Similarity |
NPD1510 |
Phase 2 |
0.8931 |
High Similarity |
NPD1240 |
Approved |
0.8913 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8841 |
High Similarity |
NPD1511 |
Approved |
0.8797 |
High Similarity |
NPD1607 |
Approved |
0.8777 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8759 |
High Similarity |
NPD3750 |
Approved |
0.8741 |
High Similarity |
NPD1551 |
Phase 2 |
0.8741 |
High Similarity |
NPD2796 |
Approved |
0.8714 |
High Similarity |
NPD1512 |
Approved |
0.8682 |
High Similarity |
NPD1203 |
Approved |
0.8521 |
High Similarity |
NPD5403 |
Approved |
0.8511 |
High Similarity |
NPD5401 |
Approved |
0.8425 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8394 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8372 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.8358 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8357 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8356 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8346 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8345 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.831 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8308 |
Intermediate Similarity |
NPD9717 |
Approved |
0.8299 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8288 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8258 |
Intermediate Similarity |
NPD2797 |
Approved |
0.8255 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8243 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8231 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8214 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8195 |
Intermediate Similarity |
NPD2798 |
Approved |
0.8182 |
Intermediate Similarity |
NPD3225 |
Approved |
0.8133 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8121 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8108 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8088 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8088 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8074 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.8067 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8067 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8054 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8054 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8028 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8028 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8014 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7973 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7955 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7943 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7943 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7907 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7902 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7852 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7834 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7821 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.782 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7817 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7793 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7786 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7785 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7785 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7762 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7736 |
Intermediate Similarity |
NPD7472 |
Approved |
0.773 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7724 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD943 |
Approved |
0.7714 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7698 |
Intermediate Similarity |
NPD411 |
Approved |
0.7698 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7681 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.766 |
Intermediate Similarity |
NPD447 |
Suspended |
0.766 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD920 |
Approved |
0.7647 |
Intermediate Similarity |
NPD4288 |
Approved |
0.764 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.763 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7626 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7625 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7597 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7591 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7574 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7571 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7559 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7559 |
Intermediate Similarity |
NPD74 |
Approved |
0.7554 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7538 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7536 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7482 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.748 |
Intermediate Similarity |
NPD9263 |
Approved |
0.748 |
Intermediate Similarity |
NPD9267 |
Approved |
0.748 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7452 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7447 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7438 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7426 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7415 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7407 |
Intermediate Similarity |
NPD17 |
Approved |
0.74 |
Intermediate Similarity |
NPD2532 |
Approved |
0.74 |
Intermediate Similarity |
NPD2534 |
Approved |
0.74 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7391 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7388 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7388 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7355 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7343 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7292 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7285 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD919 |
Approved |
0.7266 |
Intermediate Similarity |
NPD968 |
Approved |
0.7246 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7226 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7203 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7203 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7188 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7188 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7165 |
Intermediate Similarity |
NPD9261 |
Approved |
0.7161 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7143 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7118 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7115 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7115 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7113 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.711 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7091 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7086 |
Intermediate Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7047 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7039 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7034 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7029 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7024 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7024 |
Intermediate Similarity |
NPD8312 |
Approved |
0.702 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2366 |
Approved |
0.7 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD955 |
Approved |
0.6993 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD2354 |
Approved |
0.6953 |
Remote Similarity |
NPD846 |
Approved |
0.6953 |
Remote Similarity |
NPD940 |
Approved |
0.6948 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6947 |
Remote Similarity |
NPD290 |
Approved |
0.6947
|
Remote Similarity |
NPD9265 |
Clinical (unspecified phase) |